Abstract:Jie Hu, 1, 2, &ast Lin Ouyang, 3, &ast Jinxiu Li, 1 Xia Li, 2 Yanjun Zhong, 1 Can Hou 2 1 Critical Care Medicine Center, The Second Xiangya Hospital, Central South University, Changsha, People's Republic of China; 2 National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology, Key Laboratory Diseases Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China; 3 Department of Critical Care Medicine Center, Guilin Hospital of the Second Xiangya Hospital, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Can Hou, National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology, Key Laboratory Diseases Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China, Email Yanjun Zhong, Critical Care Medicine Center, The Second Xiangya Hospital, Center South University, Changsha, People's Republic of China, Email Objective: To investigate the potential prognostic value of mean blood glucose (MBG) in hospital for prognosis of COVID-19 adult patients in the intensive unit care unit (ICU). Methods: A single-site and retrospective study enrolled 107 patients diagnosed as COVID-19 from department of critical care medicine in the Second Xiangya Hospital between October 2022 and June 2023. Demographic information including glucose during ICU hospitalization, comorbidity, clinical data, types of medications and treatment, and clinical outcome were collected. The multivariate logistic and cox regression was used to explore the relationship between blood glucose changes and clinical outcomes of COVID-19 during ICU stay. Results: In total, 107 adult patients confirmed with COVID-19 were included. Multivariate logistic regression results showed an increase in MBG was associated with ICU mortality rate. Compared with normal glucose group (MBG 7.8mmol/L). Conclusion: MBG level during ICU hospitalization was strongly correlated to all-cause mortality and co-infection in COVID-19 patients. These findings further emphasize the importance of overall glucose management in severe cases of COVID-19. Keywords: mean blood glucose, intensive care medicine, ICU mortality, COVID-19 Critically ill patients often have glucose dysfunction due to complex factors such as glucagon, adipokines and insulin resistance, manifested as stress hyperglycemia, hypoglycemia and high glucose variability. 1 During the COVID-19 pandemic, a number of studies found that COVID-19 infection can cause glucose abnormalities. 2,3 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection reduced insulin sensitivity by damaging pancreatic beta cell, on the other hand, increased insulin resistance due to inflammatory cytokines release, thereby aggravating organ dysfunction of patients. 4 In addition, Emmanuelle et al in 2021 reported increased susceptibility to SARS-CoV-2 in type 2 diabetes patients, 5 while Zhu et al published in Cell Metabolism concluded that the survival rate with good glucose control was higher than with poor control of COVID-19 patients staying in ICU with diabetes. 6 Recently, a cohort study illustrated that enhanced prehospital glucose levels increased the risk of 30-day mortality of COVID-19 patients. 7 As COVID-19 patients hospitalized in intensive care units (ICU), there were some reports found that inpatient blood glucose was strongly associated with ICU mortality. 8,9 Another research reported that higher glucose variability within 24 hours of patients enrolled to ICU was significantly associated with the 30-days ICU mortality. However, the relationship between the average blood glucose level during ICU stay and ICU mortality has still not been reported. Our study primarily explored the potential relationship between average blood glucose during ICU hospitalization and the mortality of COVID-19 patients admitted to ICU, so as further to explore the new paradigm of glucose management in critical ill patients. 126 patients were admitted to the Department of Critical Care Medicine of the Second Xiangya Hospital of Central South University with confirmed COVID-19 diagnosis from October 2022 to June 2023, and all patients diagnosed according to -Abstract Truncated-

The Impact of Blood Glucose Level on the Clinical Outcomes of Patients Hospitalized with Community-Acquired Pneumonia: A Multicenter, Retrospective Study

Propensity Score Study of the Relationship Between Random Blood Glucose Level and Clinical Outcomes of Elderly Patients with Community-Acquired Pneumonia

The Impact of Diabetes on Mortality in Inpatients from Medical Department of A Chinese Tertiary Hospital

Effect of hyperglycaemia on inflammatory and stress responses and clinical outcome of pneumonia in non-critical-care inpatients: results from an observational cohort study

A Retrospective Study of 268 Patients with SARS-CoV-2 Infection to Evaluate the Association Between Blood Glucose and Severity of COVID-19 Pneumonia and Patient Mortality.

Admission fasting plasma glucose is an independent risk factor for 28‐day mortality in patients with COVID‐19

Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study

Relationship Between Hyperglycaemia at Admission and Prognosis in Patients with Acute Myocardial Infarction: a Retrospective Cohort Study

Maximum blood glucose levels during hospitalisation to predict mortality in patients with acute coronary syndrome: a retrospective cohort study

Blood Glucose Levels and Mortality in Patients With Sepsis: Dose–Response Analysis of Observational Studies

Admission Blood Glucose and 2-Year Mortality After Acute Myocardial Infarction in Patients With Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry

Comprehensive comparison of clinicoradiological, laboratory, and prognostic factors of community-acquired pneumonia in diabetic and nondiabetic hospitalized patients

Longitudinal trajectories of blood glucose and 30-day mortality in patients with diabetes mellitus combined with acute myocardial infarction: A retrospective cohort analysis of the MIMIC database

Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC‐IV database

Admission Blood Glucose Associated with In-Hospital Mortality in Critically III Non-Diabetic Patients with Heart Failure: A Retrospective Study

Relationship between glycated hemoglobin, Intensive Care Unit admission blood sugar and glucose control with ICU mortality in critically ill patients

Effect of elevated fasting blood glucose level on the 1‐year mortality and sequelae in hospitalized COVID‐19 patients: A bidirectional cohort study

Inflammatory and endothelial host responses in community-acquired pneumonia: exploring the relationships with HbA1c, admission plasma glucose, and glycaemic gap—a cross-sectional study

Hyperglycemia is associated with worse 3-year survival in older patients admitted to the intensive care unit after non-cardiac surgery: <i>Post hoc</i> analysis of a randomized trial

Effect of 24 h glucose fluctuations on 30-day and 1-year mortality in patients with acute myocardial infarction: an analysis from the MIMIC-III database

Mean Blood Glucose Level During ICU Hospitalization is a Strong Predictor of the Mortality of COVID-19